Marimed (MRMD) Accounts Payables (2011 - 2026)

Marimed (MRMD) has 16 years of Accounts Payables data on file, last reported at $15.1 million in Q1 2026.

• Accounts Payables for Q1 2026 came in at $15.1 million, up 8.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.1 million (up 8.16% YoY), and the FY2025 annual result was $14.6 million, up 10.59% from the prior year.
• Accounts Payables climbed to $15.1 million in Q1 2026 per MRMD's latest filing, from $14.6 million in the prior quarter.
• Over five years, Accounts Payables peaked at $15.1 million in Q1 2026 and troughed at $4.7 million in Q1 2023.
• A 5-year average of $10.3 million and a median of $10.3 million in 2024 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2023 and 2024: Accounts Payables plunged 43.87% in 2023, then soared 119.85% in 2024.
• A 5-year view of Accounts Payables shows it stood at $6.6 million in 2022, then soared by 35.84% to $9.0 million in 2023, then soared by 46.53% to $13.2 million in 2024, then gained by 10.59% to $14.6 million in 2025, then increased by 3.59% to $15.1 million in 2026.
• Business Quant data shows MRMD's Accounts Payables at $15.1 million in Q1 2026, $14.6 million in Q4 2025, and $11.2 million in Q3 2025.